The Q2 earnings report for ResMed RMD was released on Thursday, January 30, 2025 at 04:05 PM.
Here’s what investors need to know about the latest announcement.
Earnings
ResMed beat estimated earnings by 5.0%, reporting an EPS of $2.43 versus an estimate of $2.31.
Revenue was up $119.00 million from the same period last year.
Past Earnings Performance
During the previous quarter, the company beat on EPS by $0.16, leading to a 7.000000000000001% increase share price change the next day.
Here’s a look at ResMed’s past performance:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | 2.04 | 2.06 | 1.91 | 1.79 |
| EPS Actual | 2.20 | 2.08 | 2.13 | 1.88 |
| Revenue Estimate | 1.18B | 1.19B | 1.17B | 1.15B |
| Revenue Actual | 1.23B | 1.22B | 1.20B | 1.16B |
To track all earnings releases for ResMed visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
